Long-Term Efficacy of Tenofovir Disoproxil Fumarate Therapy in Nucleos(t)ide-Experienced Chronic Hepatitis B Patients.
- Published in:
- Clinical Drug Investigation, 2016, v. 36, n. 6, p. 471, doi. 10.1007/s40261-016-0392-0
- By:
- Publication type:
- Article
Works matching IS 11732563 AND DT 2016 AND VI 36 AND IP 6
Results: 9
1
2
Cost-Minimisation Analysis of Paliperidone Palmitate Long-Acting Treatment versus Risperidone Long-Acting Treatment for Schizophrenia in Spain.
- Published in:
- Clinical Drug Investigation, 2016, v. 36, n. 6, p. 479, doi. 10.1007/s40261-016-0393-z
- By:
- Publication type:
- Article
3
Health-Related Quality of Life During Routine Treatment with the SQ-Standardised Grass Allergy Immunotherapy Tablet: A Non-Interventional Observational Study.
- Published in:
- Clinical Drug Investigation, 2016, v. 36, n. 6, p. 453, doi. 10.1007/s40261-016-0388-9
- By:
- Publication type:
- Article
4
In Vitro and In Vivo Interaction Studies Between Lesinurad, a Selective Urate Reabsorption Inhibitor, and Major Liver or Kidney Transporters.
- Published in:
- Clinical Drug Investigation, 2016, v. 36, n. 6, p. 443, doi. 10.1007/s40261-016-0386-y
- By:
- Publication type:
- Article
5
Tumour Risk with Once-Weekly Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes Mellitus Patients: A Systematic Review.
- Published in:
- Clinical Drug Investigation, 2016, v. 36, n. 6, p. 433, doi. 10.1007/s40261-016-0389-8
- By:
- Publication type:
- Article
6
Pharmacokinetics, Pharmacodynamics and Safety of Multiple-Infusion Ilaprazole in Healthy Chinese Subjects.
- Published in:
- Clinical Drug Investigation, 2016, v. 36, n. 6, p. 463, doi. 10.1007/s40261-016-0390-2
- By:
- Publication type:
- Article
7
Factors Related to Early Clinical Effects of Quetiapine Extended-Release: A Multinational, Prospective, Observational Study.
- Published in:
- Clinical Drug Investigation, 2016, v. 36, n. 6, p. 491, doi. 10.1007/s40261-016-0395-x
- By:
- Publication type:
- Article
8
Tafluprost Ophthalmic Solution 0.0015 %: A Review in Glaucoma and Ocular Hypertension.
- Published in:
- Clinical Drug Investigation, 2016, v. 36, n. 6, p. 499, doi. 10.1007/s40261-016-0413-z
- By:
- Publication type:
- Article
9
The Safety of Erythropoiesis-Stimulating Agents for the Treatment of Anemia Resulting from Chronic Kidney Disease.
- Published in:
- Clinical Drug Investigation, 2016, v. 36, n. 6, p. 421, doi. 10.1007/s40261-016-0378-y
- By:
- Publication type:
- Article